2022年《非重症住院成人患者高血糖的管理:临床实践指南》解读  

Interpretation of“Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings:An Endocrine Society Clinical Practice Guideline”(2022 edition)

作　　者：吴太琴 甘秀妮[1] 高燕 WU Taiqin;GAN Xiuni;GAO Yan(The Second Affiliated Hospital of Chongqing Medical University,Chongqing 400010,China)

机构地区：[1]重庆医科大学附属第二医院,重庆400010

出　　处：《重庆医学》2024年第10期1441-1445,共5页Chongqing medicine

摘　　要：美国内分泌学会于2022年6月发布了《非重症住院成人患者高血糖的管理:临床实践指南》,对糖尿病和/或高血糖患者住院管理的10个临床要点提供了15项循证建议,该文旨在对其进行解读,为非重症住院成人患者高血糖的管理提供可行、安全的血糖控制方案,为规范医护人员临床操作提供指导,从而改善患者不良预后,提高生活质量。The American Endocrine Society released“Management of Hyperglycemia in Hospitalized Adult Patients in Non-Critical Care Settings:an EAndocrine Society Clinical Practice Guideline”in June 2022,which provides 15 evidence-based recommendations for ten clinical points of hospitalization management for patients with diabetes and/or hyperglycemia.The purpose of this paper is to interpret it,to provide a feasible and safe blood glucose control programs for the management of hyperglycemia in non-severe inpatient adults,and provide guidance for standardizing clinical operation of medical staff,so as to improve patients’poor prognosis and improve the quality of life.

关 键 词：高血糖 糖尿病 非重症 血糖管理 指南解读 

分 类 号：R587.1[医药卫生—内分泌]